Adverse Pregnancy Outcomes Associated With in Utero Exposure to Multiple Sclerosis Disease-Modifying Therapies in France: A Nationwide Cohort Study

被引：0
|
作者：
Swital, Morgane [1 ]
Drouin, Jerome [1 ]
Miranda, Sara [2 ]
Botton, Jeremie [1 ]
Dray-Spira, Rosemary [1 ]
机构：
[1] EPI PHARE, French Natl Agcy Med & Hlth Prod Safety ANS, French Natl Hlth Insurance CNAM, 143-147 Blvd Anatole France, F-93285 St Denis, France
[2] EPI PHARE, ANSM, CNAM, Paris, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
190
引用
收藏
页码：61 / 62
页数：2
相关论文
共 50 条
  • [1] Adverse pregnancy outcomes associated with in utero exposure to multiple sclerosis disease-modifying therapies in France: A nationwide cohort study
    Swital, Morgane
    Drouin, Jerome
    Miranda, Sara
    Botton, Jeremie
    Dray-Spira, Rosemary
    NEUROTOXICOLOGY AND TERATOLOGY, 2024, 104
  • [2] Impact of Disease-modifying Therapies on Pregnancy Outcomes in Multiple Sclerosis: A cohort study from the German Multiple Sclerosis and Pregnancy Registry
    Bast, Nadine
    Dost-Kovalsky, Karen
    Haben, Sabrina
    Friedmann, Natalia
    Witt, Laura
    Oganowski, Theresa
    Gold, Ralf
    Thiel, Sandra
    Hellwig, Kerstin
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 86 - 86
  • [3] Pregnancy in women with multiple sclerosis in France from 2010 to 2015: Incidence, outcomes, and exposure to disease-modifying therapies
    Tillaut, Helene
    Degremont, Adeline
    Kerbrat, Sandrine
    Roux, Jonathan
    Le Page, Emmanuelle
    Mainguy, Christelle
    Duros, Solene
    Polard, Elisabeth
    Leray, Emmanuelle
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (05) : 778 - 789
  • [4] Use of multiple sclerosis disease-modifying therapies during pregnancy in France: Nationwide study between 2010 and 2021
    Swital, Morgane
    Drouin, Jerome
    Miranda, Sara
    Bakchine, Serge
    Botton, Jeremie
    Dray-Spira, Rosemary
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (02) : 227 - 237
  • [5] Impact of disease-modifying therapies on pregnancy outcomes in multiple sclerosis: a prospective cohort study from the German multiple sclerosis and pregnancy registry
    Bast, Nadine
    Dost-Kovalsky, Karen
    Haben, Sabrina
    Friedmann, Natalia
    Witt, Laura
    Oganowski, Theresa
    Gold, Ralf
    Thiel, Sandra
    Hellwig, Kerstin
    LANCET REGIONAL HEALTH-EUROPE, 2025, 48
  • [6] Pregnancy exposure to disease-modifying drugs in multiple sclerosis: a prospective study
    Pablo Cuello, Juan
    Salgado Camara, Paula
    Garcia Dominguez, Jose Manuel
    Lozano Ros, Alberto
    Mas Serrano, Miguel
    Martinez Gines, Maria Luisa
    MEDICINA CLINICA, 2020, 154 (06): : 214 - 217
  • [7] Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies
    Simone, Isabella Laura
    Tortorella, Carla
    Ghirelli, Alma
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [8] Disease-modifying therapies for multiple sclerosis in association with pregnancy: a Swedish nation-wide cohort study
    Gorczyca, A.
    Alping, P.
    Frisell, T.
    Piehl, F.
    Langer-Gould, A.
    Fink, K.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 146 - 147
  • [9] Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort
    Melesse, Dessalegn Y.
    Marrie, Ruth Ann
    Blanchard, James F.
    Yu, Bo Nancy
    Evans, Charity
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1093 - 1101
  • [10] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
12345